Ropes & Gray is representing Bain Capital in the $365 million sale of two Chinese portfolio companies to the French chemical company Arkema, announced on Nov. 21. The transaction is the latest in a series of matters Ropes & Gray has handled for Bain in Asia.
The two companies – Hipro Polymers, based in Zhangjiagang, China, and Casda Biomaterials, based in Hengshui, China – are predominately owned by a joint venture between privately owned Chinese specialty chemical company Feixiang Chemicals and Bain Capital.
The transaction is subject to PRC governmental approvals, with closing expected in early 2012.
The Ropes & Gray deal team was led tax partner Elaine Murphy and associate David Morris, both in Boston.
Ropes & Gray has advised Bain on several noteworthy transactions in Asia over the past year, including its:
- $2.1 billion proposed acquisition of restaurant chain Skylark in Japan;
- acquisition of MYOB, Australia’s largest business software developer;
- $489 million sale of China’s Feixiang Chemicals
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.